Mark R. Bamforth

Brammer Bio
President & CEO
Mark Bamforth founded Brammer Bio, a best-in-class viral vector contract and development manufacturing organization (CDMO) supporting cell and gene therapy innovators. Brammer’s team has grown rapidly from 110 in 2016 to over 600 today. Brammer is based in Alachua, FL, for process development and clinical manufacturing, and in Cambridge and Lexington, MA, for commercial manufacturing.
In 2010, Bamforth founded a biologics CDMO, Gallus BioPharmaceuticals, and acquired a world-class facility and team in St. Louis, MO, with a commercial supply agreement with Janssen. Gallus tripled through organic growth and merging with Laureate Biopharma. Gallus was sold to DPx Holdings B.V. in 2014.
Bamforth previously had 22 years of experience in the UK and USA running a diverse, global manufacturing operation and a pharmaceutical CMO business for Genzyme and served as a corporate officer for 9 years. He began his career as a petroleum engineer exploring for North Sea oil with Britoil, then as a chemical engineer in the whisky industry with Whitbread. Bamforth serves on the boards of Avid Bioservices, MassBio, Wentworth Institute of Technology, and Entrepreneurial Scotland. He has a BS in Chemical Engineering from Strathclyde University and an MBA from Henley Management College.